Neşe Devenot is the Medicine, Society and Culture Postdoctoral Scholar in Bioethics at the Case Western Reserve University School of Medicine. Previously, she was a founder of the Psychedemia interdisciplinary psychedelics conference, a Research Fellow at the New York Public Library’s Timothy Leary Papers, and a Research Fellow with the New York University Psilocybin Cancer Anxiety Study. She was awarded Best Humanities Publication in Psychedelic Studies from Breaking Convention and received a Women of the Psychedelic Renaissance grant from Cosmic Sister. Her research explores the function of metaphor and other creative uses of language in descriptions of psychedelic experiences, as well as abuses of power and hegemonic social forces within the psychedelic community.
April 28, 2023
This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the people involved in promoting the Church and its claims.
May 3, 2023
Psymposia’s investigation into the Church of Psilomethoxin (CoP) turns to the Church’s claims that it’s currently “scientifically impossible” to test for psilomethoxin. Psychedelic chemist David Nichols calls that claim “completely nonsensical and nonscientific.
May 9, 2023
The Church of Psilomethoxin now admits that its claims about psilomethoxin are solely based on faith. But how strong are the religious convictions of the Church?
May 15, 2023
The Church of Psilomethoxin claims it’s the victim of “psychedelic capitalism,” but almost everything it claims is wrong.
June 6, 2023
In order to present at Psychedelic Science 2023, speakers must agree to two out-of-the-ordinary requests about content exclusivity and MAPS’ reputation.
June 21, 2023
All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list.
July 11, 2024
Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns.